RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 Bivalirudin Not Superior to Unfractionated Heparin in Patients Receiving 600 mg Clopidogrel Prior to PCI
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 2
SP 8
OP 9
DO 10.1177/155989770800800204
UL http://mdc.sagepub.com/content/8/2/8.abstract
AB Bivalirudin failed to show a superior “net clinical benefit” compared with unfractionated heparin (UFH) in patients undergoing percutaneous coronary intervention in the Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment 3 [ISAR-REACT 3] trial. However, bivalirudin reduced the rate of major and minor bleeding events in this patient population.